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Background: Recent studies suggested the potential of EPCs for neovascularization and re-endothelization, but the difficulty of obtaining sufficient 
cells has been an obstacle to the therapeutic use of blood-derived EPCs. MSCs have great advantages for cell therapy such as ease of preparation 
and great plasticity. In this study, we hypothesize that small molecules induce MSCs differentiation into endothelial like cells through regulating 
protein kinase activity and the differentiated cells show the greater beneficial effects on the re-endothelization in balloon-injured rat model.
Methods & Results: We screened chemical libraries and found that subfamily of GSK3β inhibitors cause recognizable changes in the 
differentiation rates of MSCs to endothelial cells. Among them, SB-216763 showed the greatest effect on endothelial differentiation. SB-216763 
greatly increased the expression of endothelial markers such as CD34, eNOS, VE-cadherin, VCAM-1, and VEGF-R2 in MSCs. Moreover, we observed 
that SB-216763 treated MSCs showed the greater formation of capillary-like structures compared to un-treated MSCs. SB-216763 led to depletion 
of S-phase cells and decreased overall proliferation of MSCs. We next examined if the differentiated cells increase the beneficial effects on 
vascular repair in the balloon-injured rats. MSCs or differentiated endothelial like cells were injected intravenously and the extent of vascular re-
endothelization was then assessed at 2 weeks after the injection. The denuded area was markedly reduced in the injured vessels of rat injecting 
endothelial like cells compared with control mice receiving MSCs. Immunohistochemical analysis of the endothelial marker CD31 also demonstrated 
accelerated re-endothelization of the injured artery in the endothelial like cells-injected group when compared with that in the MSCs group.
Conclusions: The inhibition of GSK-3β activity leads to the differentiation of MSCs into endothelial cells and the injection of differentiated cells 
accelerates the re-endothelization in the balloon-injured rat. This system offers a novel understanding of MSC biology and the potential for the 
development of new regenerative medicines.
